These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2854072)

  • 1. The NMDA antagonists, CPP and CGS 19755, lack affinity for central benzodiazepine receptors.
    Williams M; Loo PS; Sills MA
    Eur J Pharmacol; 1988 Oct; 155(1-2):185-7. PubMed ID: 2854072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
    Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
    Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.
    Lehmann J; Hutchison AJ; McPherson SE; Mondadori C; Schmutz M; Sinton CM; Tsai C; Murphy DE; Steel DJ; Williams M
    J Pharmacol Exp Ther; 1988 Jul; 246(1):65-75. PubMed ID: 2899170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists.
    Lodge D; Davies SN; Jones MG; Millar J; Manallack DT; Ornstein PL; Verberne AJ; Young N; Beart PM
    Br J Pharmacol; 1988 Nov; 95(3):957-65. PubMed ID: 2905186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by NMDA antagonists against selective cell loss following transient ischaemia.
    Swan JH; Meldrum BS
    J Cereb Blood Flow Metab; 1990 May; 10(3):343-51. PubMed ID: 2158499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacology of a series of 3- and 4-(phosphonoalkyl)pyridine- and -piperidine-2-carboxylic acids. Potent N-methyl-D-aspartate receptor antagonists.
    Ornstein PL; Schaus JM; Chambers JW; Huser DL; Leander JD; Wong DT; Paschal JW; Jones ND; Deeter JB
    J Med Chem; 1989 Apr; 32(4):827-33. PubMed ID: 2539478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils.
    Boast CA; Gerhardt SC; Pastor G; Lehmann J; Etienne PE; Liebman JM
    Brain Res; 1988 Mar; 442(2):345-8. PubMed ID: 3285958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioligand labeling of N-methyl-D-aspartic acid (NMDA) receptors by [3H](+-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in brain synaptic membranes treated with Triton X-100.
    Yoneda Y; Ogita K; Kouda T; Ogawa Y
    Biochem Pharmacol; 1990 Jan; 39(1):225-8. PubMed ID: 2153381
    [No Abstract]   [Full Text] [Related]  

  • 11. CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity.
    Davies J; Evans RH; Herrling PL; Jones AW; Olverman HJ; Pook P; Watkins JC
    Brain Res; 1986 Sep; 382(1):169-73. PubMed ID: 2876749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for direct interactions between the NMDA and glycine recognition sites in brain.
    Kaplita PV; Ferkany JW
    Eur J Pharmacol; 1990 Mar; 188(2-3):175-9. PubMed ID: 2156714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
    Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle relaxant and anticonvulsant activity of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents.
    Turski L; Klockgether T; Sontag KH; Herrling PL; Watkins JC
    Neurosci Lett; 1987 Jan; 73(2):143-8. PubMed ID: 3029636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGS 19755 is a potent and competitive antagonist at NMDA-type receptors.
    Lehmann J; Chapman AG; Meldrum BS; Hutchison A; Tsai C; Wood PL
    Eur J Pharmacol; 1988 Sep; 154(1):89-93. PubMed ID: 2846329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
    Löscher W; Nolting B; Hönack D
    Eur J Pharmacol; 1988 Jul; 152(1-2):9-17. PubMed ID: 3061831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-jump experiments with NMDA antagonists in mouse cultured hippocampal neurons.
    Benveniste M; Mienville JM; Sernagor E; Mayer ML
    J Neurophysiol; 1990 Jun; 63(6):1373-84. PubMed ID: 1972740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of NMDA receptors labelled with [3H]3-((+-)-2-carboxypiperazin-4-yl) propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains.
    Porter RH; Cowburn RF; Alasuzoff I; Briggs RS; Roberts PJ
    Eur J Pharmacol; 1992 Mar; 225(3):195-201. PubMed ID: 1387617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.